Cargando…
Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor
Background: The ability of ErbB3 receptor to functionally complement ErbB1-2 and induce tumor resistance to their inhibitors makes it a unique target in cancer therapy by monoclonal antibodies. Here we report the expression, purification and structural analysis of a new anti-ErbB3 single-chain antib...
Autores principales: | Eliseev, Igor E., Yudenko, Anna N., Vysochinskaya, Vera V., Svirina, Anna A., Evstratyeva, Anna V., Drozhzhachih, Maria S., Krendeleva, Elena A., Vladimirova, Anna K., Nemankin, Timofey A., Ekimova, Viktoria M., Ulitin, Andrey B., Lomovskaya, Maria I., Yakovlev, Pavel A., Bukatin, Anton S., Knyazev, Nickolay A., Moiseenko, Fedor V., Chakchir, Oleg B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097396/ https://www.ncbi.nlm.nih.gov/pubmed/30430004 http://dx.doi.org/10.12688/f1000research.13612.2 |
Ejemplares similares
-
Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama
por: Eliseev, Igor E., et al.
Publicado: (2021) -
Cadmium SAD phasing at CuKα wavelength
por: Eliseev, Igor E., et al.
Publicado: (2019) -
VHH-Based Bispecific Antibodies Targeting Cytokine Production
por: Nosenko, Maxim A., et al.
Publicado: (2017) -
Transcodeur BCD - binaire pur
por: Tiger, F
Publicado: (1970) -
Mechanism for nuclease regulation in RecBCD
por: Wilkinson, Martin, et al.
Publicado: (2016)